Mitchell Tang is a doctoral student in the Health Policy Management program. Prior to joining the program, Mitchell graduated in 2016 from the University of Pennsylvania, where he completed dual-degrees in computational biology and economics as part of the Vagelos Program in Life Sciences and Management (LSM). While at Penn, Mitchell was involved in research at the Penn Neurodegeneration Genomics Center, where his work focused on applying computational methods to study the genetics of late-onset Alzheimer's disease. Post-graduation, Mitchell joined the Boston Consulting Group (BCG), where he worked predominantly with healthcare clients to develop and implement initiatives across various functional areas, including developing the pricing strategy for a new digital medicine and enhancing the adherence programs at a retail pharmacy chain. Inspired by his prior research and case work experience, Mitchell is interested in studying the impact that new digital health technologies will have on our healthcare system.